1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Antimicrobial stewardship

Clostridioides difficile infection: antimicrobial prescribing

NICE guideline [NG199] Published: 23 July 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendation(s) from an individual piece of guidance

Guidance:
Clostridioides difficile infection: antimicrobial prescribing
Date issued:
23 July 2021

Research recommendations coming out of this guidance

  • Oral teicoplanin compared with oral vancomycin or oral fidaxomicin for treating Clostridioides difficile infection: What is the clinical effectiveness, cost effectiveness and safety of oral teicoplanin 100 mg to 200 mg twice a day for 7 to 14 days compared with oral vancomycin or oral fidaxomicin for treating C. difficile infection in adults?